Analystreport

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "hold (c+)" rating reaffirmed by analysts at Weiss Ratings.

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report